2.05
price down icon7.24%   -0.16
after-market Dopo l'orario di chiusura: 2.15 0.10 +4.88%
loading

Celularity Inc Borsa (CELU) Ultime notizie

pulisher
Feb 01, 2025

Celularity files to sell 6.52M shares of Class A common stock, warrants - MSN

Feb 01, 2025
pulisher
Jan 27, 2025

Celularity cancels material agreement with investor - MSN

Jan 27, 2025
pulisher
Jan 27, 2025

Celularity amends warrant terms, secures $2.46 million funding By Investing.com - Investing.com Canada

Jan 27, 2025
pulisher
Jan 27, 2025

Celularity amends warrant terms, secures $2.46 million funding - Investing.com India

Jan 27, 2025
pulisher
Jan 27, 2025

MASS Coalition Welcomes Trump Order Freezing Skin Substitute LCDs - The Manila Times

Jan 27, 2025
pulisher
Jan 25, 2025

Celularity cancels material agreement with investor By Investing.com - Investing.com

Jan 25, 2025
pulisher
Jan 24, 2025

Celularity Faces Challenges as Agreement Expires - TipRanks

Jan 24, 2025
pulisher
Jan 21, 2025

Celularity Inc. (NASDAQ:CELU) Short Interest Up 7.1% in December - Defense World

Jan 21, 2025
pulisher
Jan 11, 2025

Celularity (NASDAQ:CELU) Shares Down 0.5% – Here’s What Happened - Defense World

Jan 11, 2025
pulisher
Jan 03, 2025

Amniotic Products Global Industry Report 2025: Growth in Regenerative Medicine Propels the Use of Amniotic Products in Tissue Repair and Healing - GlobeNewswire Inc.

Jan 03, 2025
pulisher
Dec 22, 2024

**Celularity Inc. Holds Annual Meeting and Reports Voting Results** - Defense World

Dec 22, 2024
pulisher
Dec 10, 2024

CELUCelularity Inc. Latest Stock News & Market Updates - StockTitan

Dec 10, 2024
pulisher
Dec 10, 2024

Celularity announces resolution of Nasdaq listing compliance matter - Nasdaq

Dec 10, 2024
pulisher
Dec 10, 2024

Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter - The Manila Times

Dec 10, 2024
pulisher
Dec 10, 2024

Celularity Restores Nasdaq Compliance After Major Financial Reporting Overhaul - StockTitan

Dec 10, 2024
pulisher
Dec 07, 2024

Celularity reports Q3 EPS (73c) vs. ($4.98) last year - MSN

Dec 07, 2024
pulisher
Dec 06, 2024

Celularity Gets Back On Track With Quarterly Submissions; Q3 Revenue Jump 145% - Nasdaq

Dec 06, 2024
pulisher
Dec 06, 2024

Celularity Reports Over Sevenfold Growth in Net Product Sales through Third Quarter 2024 Compared to Third Quarter 2023 - The Manila Times

Dec 06, 2024
pulisher
Dec 06, 2024

Celularity Reports Over Sevenfold Growth in Net Product Sales through Third Quarter 2024 Compared to Third - EIN News

Dec 06, 2024
pulisher
Dec 06, 2024

Celularity Inc. (CELU) reports earnings - Quartzy

Dec 06, 2024
pulisher
Dec 06, 2024

Celularity Reports Explosive 621% Product Sales Growth, Returns to Nasdaq Compliance - StockTitan

Dec 06, 2024
pulisher
Dec 03, 2024

Celularity Inc. announced that it expects to receive $1 million in funding - Marketscreener.com

Dec 03, 2024
pulisher
Nov 29, 2024

Celularity Inc faces Nasdaq delisting over late filing By Investing.com - Investing.com South Africa

Nov 29, 2024
pulisher
Nov 29, 2024

Celularity Inc faces Nasdaq delisting over late filing - Investing.com

Nov 29, 2024
pulisher
Nov 28, 2024

Celularity Inc. Announces Receipt of Nasdaq Notification - The Manila Times

Nov 28, 2024
pulisher
Nov 27, 2024

Celularity announces receipt of Nasdaq notification - MSN

Nov 27, 2024
pulisher
Nov 27, 2024

Celularity faces Nasdaq delisting over filing delay - Investing.com India

Nov 27, 2024
pulisher
Nov 27, 2024

Celularity Faces Nasdaq Non-Compliance Notice Over Delayed Q3 Filing | CELU Stock News - StockTitan

Nov 27, 2024
pulisher
Nov 21, 2024

Genting breaks ground on stem cell facility in Bali, Indonesia - theSun

Nov 21, 2024
pulisher
Nov 20, 2024

Celularity's Strategic Partner Announces Groundbreaking for State-of-the-Art Stem Cell & Regenerative Medicine Center in Asia Pacific - The Manila Times

Nov 20, 2024
pulisher
Nov 20, 2024

Celularity Partners with Genting to Build $7.2B Market-Targeting Stem Cell Facility in Bali | CELU Stock News - StockTitan

Nov 20, 2024
pulisher
Nov 18, 2024

Celularity Resolves Nasdaq Compliance Issue, Maintains Listing After Filing Reports | CELU Stock News - StockTitan

Nov 18, 2024
pulisher
Nov 17, 2024

Celularity Inc. (NASDAQ:CELU) Sees Large Increase in Short Interest - MarketBeat

Nov 17, 2024
pulisher
Nov 11, 2024

After-Market Momentum: Celularity (CELU) Shares Climb On Increased Guidance - Stocks Telegraph

Nov 11, 2024
pulisher
Nov 09, 2024

Celularity sets annual meeting date, stockholder proposal deadline By Investing.com - Investing.com Canada

Nov 09, 2024
pulisher
Nov 08, 2024

Celularity sets annual meeting date, stockholder proposal deadline - Investing.com India

Nov 08, 2024
pulisher
Nov 07, 2024

Celularity Inc. (CELU) Quarterly 10-Q Report - Quartzy

Nov 07, 2024
pulisher
Nov 07, 2024

Celularity Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 - Marketscreener.com

Nov 07, 2024
pulisher
Nov 07, 2024

U.S. Stock market: Celularity(+52.68%), Applovin(+45.14%), FARO Technologies(+33.01%) and others were among the top gainers during mid day trading - Business Upturn

Nov 07, 2024
pulisher
Nov 07, 2024

Celularity Raises Full Year 2024 Guidance as Expected Net Sales Through October Reach $44.4 Million - The Manila Times

Nov 07, 2024
pulisher
Nov 07, 2024

Celularity Raises 2024 Sales Forecast to $60M After Record-Breaking October Revenue | CELU Stock News - StockTitan

Nov 07, 2024
pulisher
Oct 31, 2024

CELU stock touches 52-week low at $1.55 amid market fluctuations - Investing.com India

Oct 31, 2024
pulisher
Oct 30, 2024

CELU stock touches 52-week low at $1.55 amid market fluctuations By Investing.com - Investing.com South Africa

Oct 30, 2024
pulisher
Oct 26, 2024

Celularity reports over $24 million in biomaterial revenue By Investing.com - Investing.com Australia

Oct 26, 2024
pulisher
Oct 26, 2024

Celularity Inc. Announces Anticipated Revenues for Second and Third Quarters - Defense World

Oct 26, 2024
pulisher
Oct 25, 2024

Celularity reports over $24 million in biomaterial revenue - Investing.com India

Oct 25, 2024
$39.42
price down icon 3.95%
$351.17
price down icon 0.32%
$21.50
price down icon 3.85%
$5.30
price down icon 2.03%
biotechnology ONC
$224.99
price down icon 0.84%
$123.77
price up icon 2.39%
Capitalizzazione:     |  Volume (24 ore):